# Lidocaine Infusion or Quadratus Lumborum Block and Intrathecal Morphine, Versus Intrathecal Morphine Alone

> **NCT03658109** · EARLY_PHASE1 · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 1 (actual)

## Conditions studied

- Gynecologic Cancer

## Interventions

- **DRUG:** Lidocaine Bolus Infusion
- **PROCEDURE:** QL block
- **DRUG:** Saline Bolus Infusion
- **PROCEDURE:** Simulated QL block

## Key facts

- **NCT ID:** NCT03658109
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-24
- **Primary completion:** 2021-05-04
- **Final completion:** 2021-05-04
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Recruitment challenges due to COVID-19
- **Last updated:** 2021-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03658109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03658109, "Lidocaine Infusion or Quadratus Lumborum Block and Intrathecal Morphine, Versus Intrathecal Morphine Alone". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03658109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*